title: Compensatory reactions during impairment of granulocytic stem in patients with lung cancer receiving antitumor chemotherapy.
abstract: We compared changes in the granulocytic hemopoietic stem in patients with stage III-IV lung cancer receiving cytostatic therapy by the original CVC and standard CAM schemes. In patients treated with the CVC regimen, the granulocytic hemopoietic stem possessed more potent compensatory capacities.
authors.affiliation: Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences.
authors.forename: V E
authors.initials: VE
authors.lastname: Gol'dberg
authors.forename: V V
authors.initials: VV
authors.lastname: Zhdanov
authors.forename: M G
authors.initials: MG
authors.lastname: Matyash
authors.forename: E I
authors.initials: EI
authors.lastname: Simolina
authors.forename: T Y
authors.initials: TY
authors.lastname: Khrichkova
authors.forename: V V
authors.initials: VV
authors.lastname: Vysotskaya
authors.forename: N O
authors.initials: NO
authors.lastname: Popova
authors.forename: D A
authors.initials: DA
authors.lastname: Boldyshev
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology* / Q000627:therapeutic use; D016190:Carboplatin / Q000494:pharmacology / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use; D004317:Doxorubicin / Q000494:pharmacology / Q000627:therapeutic use; D006098:Granulocytes / Q000187:drug effects / Q000473:pathology; D006801:Humans; D019891:Leukopoiesis / Q000187:drug effects*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000503:physiopathology*; D008727:Methotrexate / Q000494:pharmacology / Q000627:therapeutic use; D014750:Vincristine / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D016190:Carboplatin; D008727:Methotrexate